Physician

Aaron Pascual, M.D.

According to 2025 Medicare claims, Aaron Pascual, M.D. (NPI: 1588928105) practices family practice in the Fort Lauderdale-Pompano Beach-Sunrise, FL market, with the plurality of this provider's patient population coming from Broward, FL. This provider's primary affiliated billing organization is CHEN NEIGHBORHOOD MEDICAL CENTERS OF SOUTH FLORIDA, LLC (NPI: 1881024800; TIN: 463960572) and primary practice location at 33319-2129.

Pascual's data goes back to 2015 and runs through 2024. Part D data shows 4,503 prescription claims across 646 beneficiaries totaling $260,493 in drug costs, led by Jardiance (Empagliflozin). DME data shows 22 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $38,246 to $260,493. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

No connected Part B records

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	77	499	$38,246
2016	14	85	$2,709
2017	19	198	$6,424
2018	31	207	$10,161
2019	26	191	$18,506
2020	15	78	$16,374
2021	274	964	$57,092
2022	498	3,867	$289,470
2023	440	4,140	$383,350
2024	646	4,503	$260,493

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	77	$3,209
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	22	22	$43,698
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

No connected Part B code-level records for 2024.

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Jardiance	Empagliflozin	47	2,880	$56,733
Eliquis	Apixaban	45	2,370	$45,286
Ozempic	Semaglutide	31	988	$28,918
Entresto	Sacubitril/Valsartan	12	660	$8,111
Breo Ellipta	Fluticasone/Vilanterol	13	390	$4,736

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Aaron Pascual, M.D.?

Tedicare shows public-source Medicare data for Aaron Pascual, M.D. (NPI 1588928105), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Aaron Pascual, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Aaron Pascual, M.D.?

Aaron Pascual, M.D. is linked to CHEN NEIGHBORHOOD MEDICAL CENTERS OF SOUTH FLORIDA, LLC (billing NPI 1881024800) in the available physician profile data.

Does Aaron Pascual, M.D. have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.